Sep 24, 2026 · 6 min
AI demand lifts Everpure as markets punish weaker forecasts
Stitch Fix Earnings; Everpure Soars; Viking Therapeutics Falls
The episode shows how investors are separating durable infrastructure demand from disappointing guidance and dilution risk during a market pullback.
- 1Stitch Fix shares fell after mixed results and a weaker-than-expected 2027 EBITDA outlook.
- 2Everpure surged after forecasting strong 2028 revenue growth tied to AI and hyperscaler demand.
- 3Viking Therapeutics declined after announcing a $500 million stock and convertible-debt offering.
Don't miss
Everpure’s upbeat 2028 revenue forecast, tied to AI and hyperscaler demand, stands out as the clearest positive market reaction.
The brief
As equities retreat, Bloomberg’s Stock Movers Report focuses on three companies whose shares are responding to sharply different signals: disappointing guidance, strong infrastructure demand, and fresh financing.
Stitch Fix fell after mixed quarterly results and a weaker-than-expected 2027 EBITDA outlook, showing how forward guidance can outweigh an otherwise uneven earnings report.
Everpure surged on an upbeat 2028 revenue forecast, with AI and hyperscaler demand providing the long-term growth case investors rewarded.
Viking Therapeutics dropped after announcing a $500 million stock and convertible-debt offering, putting dilution and capital needs at the center of its market reaction.
Together, the moves frame a market weighing future growth against execution risk and financing pressure rather than treating every headline equally.
What was said on this episode
2 statements · 2 negative
Stitch Fix shares are expected to reach their lowest price in nearly 2.5 years
“shares are on track to reach their lowest price in nearly 2.5 years”
Listen at 0:54
Mizuho analysts doubt Stitch Fix's turnaround prospects
“they really have doubts about the company's turnaround”
Listen at 1:23
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Judy Lagrou
Stitch Fix
Viking Therapeutics
Bloomberg L.P.Listen to the full episode and explore every guest, topic, and moment on PodLume.